Medinotec reports first positive EBITDA of $58,553, revenue up 15% ahead of OTCQX listing

Medinotec Inc.

First positive quarterly EBITDA of $58,553 for quarter ended Nov 30, 2022.
Revenue up 15% (pro forma) and Trachealator sales up 19%, despite 24% currency headwind.
Private placement raised $3,467,500; cash reserves sufficient through next fiscal year.
First Trachealator order of ~$10,343 placed in December 2022.
OTCQX listing on track: Form S-1 effective, 211 form filed with FINRA; ticker symbol pending.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Medinotec Inc. reported financial results for the quarter ended November 30, 2022.

Period: the quarter ended November 30, 2022
Result: reported results

Exact text from the filing

On January 19, 2023, we issued a shareholder letter press release announcing the results of operations for the quarter ended November 30, 2022

View on SEC.gov

Browse all earnings releases →

Medinotec Inc. filing history →

Source: SEC EDGAR

accession 0001663577-23-000024

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.